Variants of ADAMTS1 modify the effectiveness of statins in reducing the risk of myocardial infarction.
Peters
Bas J M
BJ
Division of Pharmacoepidemiology and Pharmacotherapy, Faculty of Science, Utrecht Institute for Pharmaceutical Sciences, University of Utrecht, Utrecht, The Netherlands.
Rodin
Andrei S
AS
Klungel
Olaf H
OH
Stricker
Bruno H Ch
BH
de Boer
Anthonius
A
Maitland-van der Zee
Anke-Hilse
AH
D051722:ADAM Proteins / Q000235:genetics*; D000071097:ADAMTS1 Protein; D016022:Case-Control Studies; D005260:Female; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D015810:Linkage Disequilibrium / Q000235:genetics; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000188:drug therapy* / Q000201:enzymology / Q000235:genetics*; D020641:Polymorphism, Single Nucleotide / Q000235:genetics*; D012307:Risk Factors; D016896:Treatment Outcome
D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D051722:ADAM Proteins; D000071097:ADAMTS1 Protein; C103859:ADAMTS1 protein, human